Skip to content

AnaptysBio, Inc. ANAB Operating margin

Operating margin at other companies

Amgen logo
AmgenAMGN
28.4%+6.6pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
24.3%-2.9pp
Gilead Sciences logo
Gilead SciencesGILD
34.9%+6.3pp
AbbVie logo
AbbVieABBV
24.4%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
-4,558.4%-9,354pp
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-267.6%-120pp

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.73B+180%
Enterprise value$1.48B+176%
P/S7.4×+1.9×

Profitability

See full
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Calculated from AnaptysBio, Inc.’s reported figures.

Based on trailing twelve months.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AnaptysBio, Inc.'s operating margin?
AnaptysBio, Inc. (ANAB) reported operating margin of 17.6% in Q1 2026.
How has AnaptysBio, Inc.'s operating margin changed year-over-year?
AnaptysBio, Inc.'s operating margin increased by 119.6% year-over-year, from -89.6% to 17.6%.
What is the long-term trend for AnaptysBio, Inc.'s operating margin?
Over 4 years (2021 to 2025), AnaptysBio, Inc.'s operating margin has grown at a -31.0% compound annual growth rate (CAGR), from -89.9% to 20.4%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.